日期 影响因子
日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:
–

Outcome of initial cord blood transplantation with FM80TBI as conditioning regimen for acute myeloid leukemia

以 FM80TBI 作为预处理方案的初始脐带血移植治疗急性髓系白血病的结果

期刊:Annals of Hematology
影响因子:2.4
doi:10.1007/s00277-026-06888-3
Akimoto, Masahiro; Tachibana, Takayoshi; Tanaka, Masatsugu; Izumi, Akihiko; Takeda, Takaaki; Fujimaki, Katsumichi; Tamai, Yotaro; Sato, Shuku; Fujita, Hiroyuki; Suzuki, Takahiro; Yamamoto, Koh; Yamazaki, Etsuko; Maeda, Nodoka; Arai, Shota; Hirose, Natsuki; Nakajima, Hideaki
白血病
发表日期：2026
文献求助 收藏

A Simplified Tea Ceremony Experience for Palliative Care Staff: A Feasibility and Acceptability Study

为临终关怀工作人员提供简化的茶道体验：可行性和接受度研究

期刊:Cureus Journal of Medical Science
影响因子:1.3
doi:10.7759/cureus.100865
Nishikori, Shuku; Taruoka, Ai; Kajita, Aki; Joyama, Susumu; Sugano, Eriko; Kamiya, Yuko; Niki, Kazuyuki; Kohno, Makie; Matsuda, Yoshinobu; Ishii, Ryouhei
发表日期：2026
文献求助 收藏

Prognostic value of upper paratracheal lymph node resection in stage IB right‑sided lung cancer: A retrospective cohort study

上气管旁淋巴结切除术对IB期右肺癌预后价值的评估：一项回顾性队列研究

期刊:Oncology Letters
影响因子:2.2
doi:10.3892/ol.2025.14883
Wang, Feng; Yu, Xiangyang; Han, Yi; Zhang, Lanjun; Liu, Shuku
肺癌
肿瘤
肿瘤免疫
发表日期：2025
文献求助 收藏

Dose-Attenuated-Polatuzumab Vedotine plus CHP vs. Dose-Attenuated -R-CHOP in Patients Aged ≥ 80 Years with Diffuse Large B-Cell Lymphoma: A Retrospective, Propensity Score-Matched Analysis Stratified by Simplified Frailty Score

剂量减低剂量维多珠单抗联合CHP方案与剂量减低剂量R-CHOP方案治疗≥80岁弥漫性大B细胞淋巴瘤患者的疗效比较：一项回顾性、倾向评分匹配分析，并按简化衰弱评分进行分层

期刊:Mediterranean Journal of Hematology and Infectious Diseases
影响因子:1.5
doi:10.4084/MJHID.2025.070
Sato, Shuku; Sawazaki, Emi; Tsunoda, Shun; Kamata, Wataru; Togano, Tomiteru; Tamai, Yotaro
B细胞
HOP
淋巴瘤
CHOP
细胞生物学
免疫/内分泌
发表日期：2025
文献求助 收藏

Case series of long-term responders to pralatrexate in peripheral T-cell lymphoma

外周T细胞淋巴瘤患者对普拉曲沙长期反应的病例系列研究

期刊:Journal of Clinical and Experimental Hematopathology
影响因子:1.4
doi:10.3960/jslrt.25013
Tomita, Naoto; Kitazume, Koichi; Kitajima, Toshiki; Hayata, Hiroki; Sato, Shuku; Nakamura, Naoya
T细胞
淋巴瘤
T细胞
细胞生物学
免疫/内分泌
发表日期：2025
文献求助 收藏

Dyssegmental dysplasia Rolland-Desbuquois type is caused by pathogenic variants in HSPG2 - a founder haplotype shared in five patients

Rolland-Desbuquois 型节段发育不良是由 HSPG2 致病变异引起的，HSPG2 是五名患者共有的创始单倍型

期刊:Journal of Human Genetics
影响因子:2.6
doi:10.1038/s10038-024-01229-6
Paniz Farshadyeganeh, Takahiro Yamada, Hirofumi Ohashi, Gen Nishimura, Hiroki Fujita, Yuriko Oishi, Misa Nunode, Shuku Ishikawa, Jun Murotsuki, Yuri Yamashita, Shiro Ikegawa, Tomoo Ogi, Eri Arikawa-Hirasawa, Kinji Ohno4
发育与干细胞
发表日期：2024
文献求助 收藏

Chemotherapy for advanced pulmonary sarcomatoid carcinoma: a population-based propensity score matching study

晚期肺肉瘤样癌的化疗：一项基于人群的倾向评分匹配研究

期刊:BMC Pulmonary Medicine
影响因子:2.8
doi:10.1186/s12890-023-02541-1
Wang, Feng; Yu, Xiangyang; Han, Yi; Gong, Changfan; Yan, Dongjie; Yang, Lei; Li, Jie; Liu, Shuku
肿瘤
肿瘤免疫
发表日期：2023
文献求助 收藏

Clinical significance of high-dose chemotherapy with autologous stem cell transplantation in the era of novel agents in patients older than 65 years with multiple myeloma

在新型药物时代，大剂量化疗联合自体干细胞移植治疗65岁以上多发性骨髓瘤患者的临床意义

期刊:Annals of Hematology
影响因子:2.4
doi:10.1007/s00277-023-05177-7
Sato, Shuku; Tsunoda, Shun; Kawahigashi, Teiko; Kamata, Wataru; Tamai, Yotaro
发育与干细胞
多发性骨髓瘤
骨髓瘤
干细胞
细胞生物学
发表日期：2023
文献求助 收藏

Evaluation of the necessity of Pulmonary Ligament Lymph Node Dissection for Upper Lobe Stage IB NSCLC: A Propensity Score-matched Study

评估肺韧带淋巴结清扫术对上叶IB期非小细胞肺癌的必要性：一项倾向评分匹配研究

期刊:Journal of Cancer
影响因子:3.2
doi:10.7150/jca.76108
Wang, Feng; Yu, Xiangyang; Han, Yi; Zhang, Lanjun; Liu, Shuku
肺癌
细胞生物学
肿瘤
肿瘤免疫
发表日期：2022
文献求助 收藏

Case Report: A Case of Myeloproliferative Neoplasm Complicated by Alopecia Areata

病例报告：一例骨髓增生性肿瘤并发斑秃的病例

期刊:Frontiers in Medicine
影响因子:3
doi:10.3389/fmed.2022.895699
Tamai, Yotaro; Teshima, Shinichi; Tsunoda, Shun; Kamata, Wataru; Sato, Shuku
肿瘤
肿瘤免疫
发表日期：2022
文献求助 收藏